Predicting response to biologics for severe asthma through breath analysis

Researchers from the University of Liège propose a new method using breath analysis to predict patient response to biologic therapies for severe eosinophilic asthma. This advancement aims to personalize treatment plans and improve outcomes by identifying likely responders before therapy begins.